Breaking News

Sandoz Creates Global Biosimilars Unit

New biosimilar development, manufacturing and supply unit will be headed by Armin Metzger.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Sandoz

Sandoz, a Swiss company that focuses on generic pharmaceuticals and biosimilars, is creating a new biosimilar development, manufacturing and supply unit that will be headed by Armin Metzger. Metzger will join Sandoz on April 1, 2026, as President, Biosimilar Development, Manufacturing & Supply and become a member of the Sandoz Executive Committee (SEC). By consolidating biosimilar development, manufacturing and supply under one SEC leader the company aims to enable clear ownership, fast d...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters